Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medco/Oxford Services Contract Is Basis Of “Kickback” Allegation In DoJ Suit

Executive Summary

Medco's $83 mil. payment to Oxford Health Plans for consultative and information services is the basis for the Philadelphia U.S. Attorney's "kickback" allegations against the PBM

You may also be interested in...



Caremark Settlement Reinforces PBM Disclosure, Rx Interchange Standards

Caremark's settlement of a federal investigation into AdvancePCS' business practices reinforces the rules for pharmacy benefit manager conduct that were first delineated in a Medco consent decree in April 2004

Caremark Settlement Reinforces PBM Disclosure, Rx Interchange Standards

Caremark's settlement of a federal investigation into AdvancePCS' business practices reinforces the rules for pharmacy benefit manager conduct that were first delineated in a Medco consent decree in April 2004

Merck Taps Clark As CEO In Nod To Medco Heritage; Gilmartin To Retire

Merck's appointment of Richard Clark to succeed retiring CEO Ray Gilmartin continues the Medco legacy at Merck's senior management level

Related Content

UsernamePublicRestriction

Register

PS042989

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel